Carol Anne Dragoo, in Aberdeen, WA - Peer Specialist

Carol Anne Dragoo, is a Peer Specialist based in Aberdeen, Washington. Carol Anne Dragoo is licensed to practice in * (Not Available) (license number ) and her current practice location is 224 E Wishkah St, Aberdeen, Washington. She can be reached at her office (for appointments etc.) via phone at (360) 532-9050.

NPI number for Carol Anne Dragoo is 1477278034 and her current mailing address is 224 E Wishkah St, Aberdeen, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1477278034.

Contact Information

	Carol Anne Dragoo,
	224 E Wishkah St, Aberdeen, WA 98520-6513
	(360) 532-9050
	Not Available

Healthcare Provider's Profile

Full Name	Carol Anne Dragoo
Gender	Female
Speciality	Peer Specialist
Location	224 E Wishkah St, Aberdeen, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1477278034
Provider Enumeration Date: 10/06/2022
Last Update Date: 11/21/2022

Medical Identifiers

Medical identifiers for Carol Anne Dragoo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477278034	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101Y00000X	Counselor	(* (Not Available))	Secondary
175T00000X	Peer Specialist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Carol Anne Dragoo is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Carol Anne Dragoo, 224 E Wishkah St, Aberdeen, WA 98520-6513 Ph: (360) 532-9050	Carol Anne Dragoo, 224 E Wishkah St, Aberdeen, WA 98520-6513 Ph: (360) 532-9050

News Archive

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.

Number of annual polio cases in Nigeria quadruples; WHO, government working to vaccinate millions of children

Nigeria has reported 43 cases of polio so far this year, up from 11 cases in 2010, and the disease has spread to Niger, Mali, and Cote d'Ivoire, according to a WHO official, BBC News reports.

New surface coating for medical devices prevents blood from clotting

From joint replacements to cardiac implants and dialysis machines, medical devices enhance or save lives on a daily basis. However, any device implanted in the body or in contact with flowing blood faces two critical challenges that can threaten the life of the patient the device is meant to help: blood clotting and bacterial infection.

Deficit in microglia during development can have long-lasting effects on brain wiring, behavior

In many people with autism and other neurodevelopmental disorders, different parts of the brain don't talk to each other very well. Scientists have now identified, for the first time, a way in which this decreased functional connectivity can come about.

Carol Anne Dragoo, - Counselor in Aberdeen, WA